APOE and Alzheimer disease: Another recent study on mice and human-derived iPSC showed that the APOE-R136S mutation antagonizes the deleterious effect of APOE4 on microglial function, providing protection against the development of the AD pathology and suggesting a possible therapeutic target [164].